您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Dyngo-4a
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Dyngo-4a
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Dyngo-4a图片
CAS NO:1256493-34-1
规格:≥98%
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议

产品介绍
理化性质和储存条件
Molecular Weight (MW)338.31
FormulaC18H14N2O5
CAS No.1256493-34-1
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 67 mg/mL (198.0 mM)
Water: <1 mg/mL
Ethanol: <1 mg/mL
Other info

Chemical Name: 3-Hydroxynaphthalene-2-carboxylic acid 2-[(2,4,5-trihydroxyphenyl)methylene]hydrazide

InChi Key: UAXHPUSKEWEOAP-DJKKODMXSA-N

InChi Code: InChI=1S/C18H14N2O5/c21-14-8-17(24)16(23)7-12(14)9-19-20-18(25)13-5-10-3-1-2-4-11(10)6-15(13)22/h1-9,21-24H,(H,20,25)/b19-9+

SMILES Code: O=C(C1=C(O)C=C2C=CC=CC2=C1)N/N=C/C3=CC(O)=C(O)C=C3O

Synonyms

Dyngo-4a; Dyngo 4a; Hydroxy Dynasore; Dyngo4a;

实验参考方法
In Vitro

In vitro activity: Dyngo-4a inhibits dynamin-dependent endocytosis of transferrin in multiple cell types with IC50 of 5.7 μM, and reduces synaptic vesicle endocytosis and activity-dependent bulk endocytosis in cultured neurons and synaptosomes. In motor nerve terminals and cultured hippocampal neurons, Dyngo-4a blocks Alexa Fluor 488-BoNT/A-Hc internalization. In Drosophila S2R+ cells, Dyngo-4a causes a decrease in the level of Armadillo/β-catenin.


Cell Assay: Dyngo-4a (100 μM) caused a reduction in β-catenin levels in human colon carcinoma RKO cells. In addition, Dyngo-4a prevented the uptake of BoNT/A-Hc and blocked BoNT/A-induced SNAP25 cleavage in cultured hippocampal neurons. Dyngo-4a is potent, reversible endocytosis inhibitor in non-neuronal cells. Dyngo-4a inhibited synaptic vesicle endocytosis (SVE) in synaptosomes and neurons with an IC50 value of 26.8 μM.

In VivoDynamin is a potential therapeutic target for counteracting botulism. Dyngo-4a (30 mg/kg, intraperitoneal injection) treatment suppressed BoNT/A-induced muscle paralysis at the rat hemidiaphragm and significantly delayed the onset of botulism in an in vivo murine model.
Animal modelMurine
Formulation & Dosage30 mg/kg, intraperitoneal injection
References

Traffic. 2013 Dec;14(12):1272-89; J Cell Sci. 2014 Nov 15;127(Pt 22):4918-26.